NH7 Stock Overview
An investment holding company, operates private hospitals in South Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Netcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R0.73 |
| 52 Week High | R0.78 |
| 52 Week Low | R0.49 |
| Beta | 0.31 |
| 11 Month Change | 2.82% |
| 3 Month Change | 17.74% |
| 1 Year Change | 17.74% |
| 33 Year Change | -7.01% |
| 5 Year Change | -36.52% |
| Change since IPO | -41.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| NH7 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 4.3% | 0.3% | -1.3% |
| 1Y | 17.7% | 15.7% | 7.4% |
Return vs Industry: NH7 exceeded the German Healthcare industry which returned 14.5% over the past year.
Return vs Market: NH7 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| NH7 volatility | |
|---|---|
| NH7 Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NH7 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NH7's weekly volatility has decreased from 8% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 18,000 | Richard Friedland | www.netcare.co.za |
Netcare Limited, an investment holding company, operates private hospitals in South Africa. The company operates through Hospital and Emergency Services, and Primary Care segments. The Hospital and Emergency Services segment engages in the hospital and pharmacy operations.
Netcare Limited Fundamentals Summary
| NH7 fundamental statistics | |
|---|---|
| Market cap | €1.01b |
| Earnings (TTM) | €67.70m |
| Revenue (TTM) | €1.27b |
14.9x
P/E Ratio0.8x
P/S RatioIs NH7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NH7 income statement (TTM) | |
|---|---|
| Revenue | R24.20b |
| Cost of Revenue | R12.23b |
| Gross Profit | R11.97b |
| Other Expenses | R10.68b |
| Earnings | R1.29b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 1.03 |
| Gross Margin | 49.47% |
| Net Profit Margin | 5.31% |
| Debt/Equity Ratio | 66.8% |
How did NH7 perform over the long term?
See historical performance and comparison